Trial result

Kidney Cancer Has a New Post-Immunotherapy Standard. Survival Is Not Settled.

Parkinson’s Is Trying to Vaccinate Against Progression

Cholangiocarcinoma Just Made FGFR2 Testing Harder to Ignore

Small-Cell Lung Cancer May Be Done Irradiating Healthy Brains

Pembrolizumab Just Lost a Head-to-Head Survival Fight

HER2-Mutant Lung Cancer Just Moved Into First Line

One Psychedelic Dose Is Now a Phase III Argument

Breast Cancer Just Proved Why Biomarker Selection Matters

Menstrual Migraine Was Never Just Regular Migraine
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
